Go to deals
Healthcare

MediCA group has been acquired by Repharm

CGP Management has sold MediCA group, the largest private provider of healthcare services in Lithuania, to Repharm.

MediCA group is present in all levels of the healthcare system with primary, specialist and hospital care being the core business areas. Primary and selected specialist care services are provided in 30 clinics across Lithuania under the brand name MediCA. Kardiolitos Klinikos, which is the only private hospital in Lithuania, has three specialist centers, located in Vilnius, Kaunas, and Šiauliai, providing inpatient and outpatient healthcare services and is a nationally acknowledged center of excellence for cardiology services.

Repharm is a Latvian group of companies providing a wide range of healthcare services, from healthy lifestyle counseling to diagnosis and treatment. The group includes Sentor Farm Aptiekas (pharmacies operating under the Mēness Aptieka brand), Veselības Centru Apvienība (a chain of private clinics), Centrālā Laboratorija (a medical laboratory), Rīgas farmaceitiskā fabrika (a manufacturer of galenic preparations, soft pharmaceuticals and herbal drugs and teas) and Recipe Plus (wholesale trader of pharmaceutical and healthcare products).

Oaklins’ team in Lithuania advised CGP Management on the sale of MediCA group to Repharm.

Parties
“We have worked with Oaklins on various M&A processes for a number of years. The team have proved themselves to be very efficient and inventive financial advisors that we could always rely on. The results achieved during the MediCa sale process have far exceeded our expectations with regard to the competition and final deal terms. We are looking forward to working on more projects with the Oaklins team.”

Alvydas Barsteiga

Member of the Board, CGP Management

Talk to the deal team

Natalja Titova

Associate Partner
Vilnius, Lithuania
Oaklins Baltics

Mindaugas Matulaitis

Associate Partner
Vilnius, Lithuania
Oaklins Baltics

Related deals

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more
EuroHospital Varna has been acquired by Intermedica Group
Healthcare

EuroHospital Varna has been acquired by Intermedica Group

EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.

Learn more
Olyos Group has acquired a controlling stake in NewScience
Healthcare

Olyos Group has acquired a controlling stake in NewScience

Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.

Learn more